We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$5.72B
AUM Growth
+$377M
Cap. Flow
-$47.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
18.31%
Holding
1,615
New
130
Increased
604
Reduced
665
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Financials 10.88%
3 Healthcare 10.31%
4 Consumer Discretionary 9.37%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONLN icon
1326
ProShares Online Retail ETF
ONLN
$66.7M
$237K ﹤0.01%
4,170
-4,506
-52% -$291K
XSMO icon
1327
Invesco S&P SmallCap Momentum ETF
XSMO
$3.09B
$237K ﹤0.01%
4,205
BCAT icon
1328
BlackRock Capital Allocation Term Trust
BCAT
$1.68B
$236K ﹤0.01%
12,145
+2,177
+22% +$42.3K
TU icon
1329
Telus
TU
$15.1B
$236K ﹤0.01%
10,012
-915
-8% -$20.9K
AY
1330
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$236K ﹤0.01%
6,599
+507
+8% +$19K
BFK
1331
DELISTED
BlackRock Municipal Income Trust
BFK
$234K ﹤0.01%
15,074
+1,368
+10% +$20.5K
BGY icon
1332
BlackRock Enhanced International Dividend Trust
BGY
$533M
$234K ﹤0.01%
37,265
+247
+0.7% +$1.53K
CAH icon
1333
Cardinal Health
CAH
$55.5B
$234K ﹤0.01%
+4,533
New +$222K
HEI icon
1334
HEICO Corp
HEI
$50.9B
$234K ﹤0.01%
1,622
-318
-16% -$44.8K
OXY.WS icon
1335
Occidental Petroleum Corp Warrants
OXY.WS
$34.5B
$234K ﹤0.01%
18,606
-286
-2% -$3.92K
AYX
1336
DELISTED
Alteryx Inc
AYX
$234K ﹤0.01%
3,871
-933
-19% -$64.4K
EMLP icon
1337
First Trust North American Energy Infrastructure Fund
EMLP
$4.1B
$232K ﹤0.01%
9,302
+351
+4% +$8.67K
RIV
1338
RiverNorth Opportunities Fund
RIV
$317M
$232K ﹤0.01%
14,551
+1,124
+8% +$19K
ALGN icon
1339
Align Technology
ALGN
$12.5B
$231K ﹤0.01%
351
-294
-46% -$189K
TRMB icon
1340
Trimble
TRMB
$13.6B
$231K ﹤0.01%
+2,655
New +$228K
EA
1341
DELISTED
Electronic Arts
EA
$230K ﹤0.01%
1,741
-586
-25% -$78.8K
MPLX icon
1342
MPLX
MPLX
$59.5B
$230K ﹤0.01%
7,766
-87,164
-92% -$2.61M
PODD icon
1343
Insulet
PODD
$9.91B
$230K ﹤0.01%
864
+14
+2% +$4.06K
BXMX
1344
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$229K ﹤0.01%
15,634
-457
-3% -$6.72K
TFII icon
1345
TFI International
TFII
$11.4B
$229K ﹤0.01%
+2,040
New +$222K
IOVA icon
1346
Iovance Biotherapeutics
IOVA
$2.9B
$227K ﹤0.01%
11,867
-3,587
-23% -$79K
ACCO icon
1347
Acco Brands
ACCO
$402M
$226K ﹤0.01%
27,368
+3,420
+14% +$29.5K
CLB icon
1348
Core Laboratories
CLB
$561M
$226K ﹤0.01%
10,137
-40
-0.4% -$1.04K
VLUE icon
1349
iShares MSCI USA Value Factor ETF
VLUE
$9.46B
$226K ﹤0.01%
+2,062
New +$217K
MNA icon
1350
IQ ARB Merger Arbitrage ETF
MNA
$253M
$225K ﹤0.01%
6,968
+169
+2% +$5.5K

Similar funds

Oppenheimer & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer & Co held 1,615 positions worth $5.72B, up 7.1% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q4 2021 filing shows 130 new, 604 increased, 665 reduced and 130 closed positions. Its largest new stake was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M. The largest sale was Global X S&P 500 Covered Call ETF, an estimated $49.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q4 2021 buy was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M.
  • Oppenheimer & Co added most to Canadian Pacific Kansas City in Q4 2021, an estimated $7.48M increase.
  • Oppenheimer & Co's biggest Q4 2021 reduction was Global X S&P 500 Covered Call ETF, cutting an estimated $49.9M.
  • Oppenheimer & Co fully exited Kansas City Southern in Q4 2021, selling an estimated $6.61M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.72B portfolio in Q4 2021.
  • Oppenheimer & Co opened 130 new positions and closed 130 in Q4 2021.
  • Oppenheimer & Co's portfolio value rose 7.1% quarter-over-quarter to $5.72B.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.